Technological Breakthrough Driving Transformation: The Path to Domestic Substitution of Core Medical Imaging Components

Focusing on investments in the biopharmaceutical and medical device sectors, led investments in companies such as Betta Pharmaceuticals (688759.SH), Sailu Medical, Weichun Biology, Juhe Biology, Weishi Optoelectronics, and Aidi Gene. Investment empowerment cases include MGI Tech (688114.SH), BGI YuanYin, Kentuo Fluidics, Maijing Gene, and Dashí Pharma.

Ph.D. in Biology from Wuhan University, specializing in investments in innovative biotechnology and medical devices. With long-term observation of the healthcare industry, possesses profound insights into the pharmaceutical equity investment market and industrial policies.

Graduated from Beijing University of Technology with a major in Microelectronics. Possesses 20 years of R&D and manufacturing management experience in CT detectors and related radiation detectors. Participated in the design and development of multiple CT detector models, which have been widely adopted in both overseas and Chinese-branded CT systems. Proficient in the principles, design, processes, and manufacturing of semiconductor optoelectronic chips. Since founding the company in 2017, has successively received awards and support from Changzhou’s “Longcheng Talent Plan” and Jiangsu Province’s “Mass Entrepreneurship and Innovation Talent” program (Entrepreneurship Category).

Ph.D. in Physics from the University of California, Irvine; listed expert in the “National Science and Technology Expert Database” of the Ministry of Science and Technology under the State Council; principal investigator for projects under the National Key R&D Program. Conducted visiting research at Brookhaven National Laboratory and Los Alamos National Laboratory in the United States from 1990 to 1993; served as a Research Fellow in Radiation Medicine at the University of California from 1993 to 1995; founded Aerosino in 1996; established SANDT through a joint venture with Shanghai Electric Group in 2001, achieving independent control over core X-ray components while actively expanding upstream into key materials and core parts, thereby driving collaborative localization of the industrial chain. After years of accumulation, SANDT has grown into a globally leading enterprise specializing in X-ray technology for medical, industrial, and other application fields.

Holding a Bachelor of Medicine in Clinical Medicine from Capital Medical University and an MBA from Peking University, she focuses on investments in the healthcare sector. Prior to this, Ms. You Linlin had many years of experience in the cardiology department of Grade A tertiary hospitals.With extensive professional experience, he has also served multinational corporations such as Abbott and Biotronik (Germany), possessing in-depth understanding and insights into the healthcare sector. Key investment projects he has led include Cossel Medical, SANDT, Sumai Medical, Huijiaya Medical, and Haiyu Xincheng.

Holding bachelor’s and master’s degrees in Nuclear Technology Applications from Tsinghua University, with nearly two decades of extensive experience in technology R&D and brand management. Responsible for the R&D and optimization of the company’s X-ray source products, expanding their applications in medical and dental scenarios, and leading global market strategy and marketing deployment. Participated in multiple key domestic and international scientific research and technological innovation projects, including the National Key R&D Program during the 14th Five-Year Plan period and projects awarded the Gold Medal at the Geneva International Exhibition of Inventions.